AMNEAL PHARMACEUTICALS, INC.
Revenue Breakdown
| Fiscal Year | Generics | Specialty |
|---|---|---|
| FY2016 | $1.17B | $248.9M |
| FY2017 | $1.18B | $242.0M |
| FY2018 | $970.4M | $196.2M |
| FY2019 | $833.6M | $177.3M |
| FY2020 | $771.6M | $183.1M |
| FY2021 | $725.7M | $249.7M |
| FY2022 | $668.6M | $268.4M |
| FY2023 | $656.9M | $335.8M |